Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Post by nemo3on Nov 13, 2014 9:15am

207 Views

Post# 23123708

rat studies

I watched that video yesterday and TLT is still planning on starting ph 1 human clinical trials early 2015. I did not hear anything more about the rat trial tho. I know the release yesterday mentions another mouse test this month. I wonder if they won't bother with rats now. of course, considering that they do this testing in under a month, they still have a couple plus months to do them in.

Bullboard Posts

Unique Battery Metals opportunity in Quebec